REDD1 Deletion Suppresses NF-κB Signaling in Cardiomyocytes and Prevents Deficits in Cardiac Function in Diabetic Mice

Shaunaci A. Stevens,Siddharth Sunilkumar,Sandeep M. Subrahmanian,Allyson L. Toro,Omer Cavus,Efosa V. Omorogbe,Elisa A. Bradley,Michael D. Dennis

DOI: https://doi.org/10.3390/ijms25126461

IF: 5.6

2024-06-13

International Journal of Molecular Sciences

Abstract:Activation of the transcription factor NF-κB in cardiomyocytes has been implicated in the development of cardiac function deficits caused by diabetes. NF-κB controls the expression of an array of pro-inflammatory cytokines and chemokines. We recently discovered that the stress response protein regulated in development and DNA damage response 1 (REDD1) was required for increased pro-inflammatory cytokine expression in the hearts of diabetic mice. The studies herein were designed to extend the prior report by investigating the role of REDD1 in NF-κB signaling in cardiomyocytes. REDD1 genetic deletion suppressed NF-κB signaling and nuclear localization of the transcription factor in human AC16 cardiomyocyte cultures exposed to TNFα or hyperglycemic conditions. A similar suppressive effect on NF-κB activation and pro-inflammatory cytokine expression was also seen in cardiomyocytes by knocking down the expression of GSK3β. NF-κB activity was restored in REDD1-deficient cardiomyocytes exposed to hyperglycemic conditions by expression of a constitutively active GSK3β variant. In the hearts of diabetic mice, REDD1 was required for reduced inhibitory phosphorylation of GSK3β at S9 and upregulation of IL-1β and CCL2. Diabetic REDD1+/+ mice developed systolic functional deficits evidenced by reduced ejection fraction. By contrast, REDD1−/− mice did not exhibit a diabetes-induced deficit in ejection fraction and left ventricular chamber dilatation was reduced in diabetic REDD1−/− mice, as compared to diabetic REDD1+/+ mice. Overall, the results support a role for REDD1 in promoting GSK3β-dependent NF-κB signaling in cardiomyocytes and in the development of cardiac function deficits in diabetic mice.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the mechanism of action of REDD1 in diabetic cardiomyopathy, especially how REDD1 promotes the development of cardiac dysfunction by influencing the NF - κB signaling pathway. Specifically, the research aims to:

1. **Explore the influence of REDD1 on the NF - κB signaling pathway**: Researchers deleted the REDD1 gene to observe its inhibitory effect on the NF - κB signaling pathway, especially under hyperglycemic conditions and TNF - α stimulation.

2. **Evaluate the role of REDD1 in the hearts of diabetic mice**: Researchers compared the cardiac functions of wild - type and REDD1 - knockout mice under diabetic conditions, especially the changes in left ventricular ejection fraction (LVEF) and left ventricular internal diameter (LVID), to evaluate the role of REDD1 in the development of diabetic cardiomyopathy.

3. **Analyze the role of GSK3β in REDD1 - dependent NF - κB activation**: Researchers knocked down GSK3β expression to observe its influence on the NF - κB signaling pathway, and further verified the role of GSK3β in REDD1 - dependent NF - κB activation by expressing a constitutively activated GSK3β variant.

In summary, the main objective of this paper is to elucidate the mechanism of action of REDD1 through the GSK3β - dependent NF - κB signaling pathway in diabetic cardiomyopathy, thereby providing new targets and ideas for the prevention and treatment of diabetic cardiomyopathy.